Abstract:
BACKGROUND:Studies have shown that industry-sponsored meta-analyses of drugs lack scientific rigour and have biased conclusions. However, these studies have been restricted to certain medical specialities. We compared all industry-supported meta-analyses of drug-drug comparisons with those without industry support. METHODS:We searched PubMed for all meta-analyses that compared different drugs or classes of drugs published in 2004. Two authors assessed the meta-analyses and independently extracted data. We used a validated scale for judging the methodological quality and a binary scale for judging conclusions. We divided the meta-analyses according to the type of support in 3 categories: industry-supported, non-profit support or no support, and undeclared support. RESULTS:We included 39 meta-analyses. Ten had industry support, 18 non-profit or no support, and 11 undeclared support. On a 0-7 scale, the median quality score was 6 for meta-analyses with non-profit or no support and 2.5 for the industry-supported meta-analyses (P < 0.01). Compared with industry-supported meta-analyses, more meta-analyses with non-profit or no support avoided bias in the selection of studies (P = 0.01), more often stated the search methods used to find studies (P = 0.02), searched comprehensively (P < 0.01), reported criteria for assessing the validity of the studies (P = 0.02), used appropriate criteria (P = 0.04), described methods of allocation concealment (P = 0.05), described methods of blinding (P = 0.05), and described excluded patients (P = 0.08) and studies (P = 0.15). Forty percent of the industry-supported meta-analyses recommended the experimental drug without reservations, compared with 22% of the meta-analyses with non-profit or no support (P = 0.57).In a sensitivity analysis, we contacted the authors of the meta-analyses with undeclared support. Eight who replied that they had not received industry funding were added to those with non-profit or no support, and 3 who did not reply were added to those with industry support. This analysis did not change the results much. CONCLUSION:Transparency is essential for readers to make their own judgment about medical interventions guided by the results of meta-analyses. We found that industry-supported meta-analyses are less transparent than meta-analyses with non-profit support or no support.
journal_name
BMC Med Res Methodoljournal_title
BMC medical research methodologyauthors
Jørgensen AW,Maric KL,Tendal B,Faurschou A,Gøtzsche PCdoi
10.1186/1471-2288-8-60subject
Has Abstractpub_date
2008-09-09 00:00:00pages
60issn
1471-2288pii
1471-2288-8-60journal_volume
8pub_type
杂志文章abstract:BACKGROUND:Controlling the false discovery rate is important when testing multiple hypotheses. To enhance the detection capability of a false discovery rate control test, we applied the likelihood ratio-based multiple testing method in neuroimage data and compared the performance with the existing methods. METHODS:We ...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/1471-2288-15-9
更新日期:2015-01-30 00:00:00
abstract:BACKGROUND:The Template for Intervention Description and Replication (TIDieR) checklist and guide was developed by an international team of experts to promote full and accurate description of trial interventions. It is now widely used in health research. The aim of this paper is to describe the experience of using TIDi...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-017-0461-y
更新日期:2018-01-18 00:00:00
abstract:BACKGROUND:The "real" effect size of a medical therapy is constant over time. In contrast, the effect size reported in randomised controlled trials (RCTs) may change over time because the sum of all kinds of bias influencing the reported effectiveness is not necessarily constant. As this would affect the validity of me...
journal_title:BMC medical research methodology
pub_type: 杂志文章,meta分析
doi:10.1186/1471-2288-6-25
更新日期:2006-05-11 00:00:00
abstract:BACKGROUND:Many medicines are dosed to achieve a particular therapeutic range, and monitored using therapeutic drug monitoring (TDM). The evidence base for a therapeutic range can be evaluated using systematic reviews, to ensure it continues to reflect current indications, doses, routes and formulations, as well as upd...
journal_title:BMC medical research methodology
pub_type: 杂志文章,评审
doi:10.1186/s12874-017-0363-z
更新日期:2017-06-02 00:00:00
abstract:BACKGROUND:Generic quality of life (QoL) instruments provide important measures of self-reported wellbeing that can be compared across healthy and clinical populations. The aim of this analysis is to validate the ten-item QoL instrument "QOL10", as well as to confirm the validity of the embedded "QOL5" questionnaire an...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-016-0163-x
更新日期:2016-05-23 00:00:00
abstract:BACKGROUND:The ethical, methodological, and technical aspects of pediatric research, often results in complications and delays in implementation. Our objective was to identify factors associated with the implementation duration of hospital-based pediatric studies. METHODS:All hospital-based pediatric studies sponsored...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-016-0138-y
更新日期:2016-03-29 00:00:00
abstract:BACKGROUND:Health researchers undertake studies which combine qualitative and quantitative methods. Little attention has been paid to the structural issues affecting this mixed methods approach. We explored the facilitators and barriers to undertaking mixed methods studies in health research. METHODS:Face-to-face semi...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/1471-2288-9-82
更新日期:2009-12-09 00:00:00
abstract:BACKGROUND:Due to limited duration of follow up in clinical trials of cancer treatments, estimates of lifetime survival benefits are typically derived using statistical extrapolation methods. To justify the method used, a range of approaches have been proposed including statistical goodness-of-fit tests and comparing e...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-020-00997-x
更新日期:2020-05-06 00:00:00
abstract:BACKGROUND:Surveys are established methods for collecting population data that are unavailable from other sources; however, response rates to surveys are declining. A number of methods have been identified to increase survey returns yet response rates remain low. This paper evaluates the impact of five selected methods...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-019-0702-3
更新日期:2019-03-20 00:00:00
abstract:BACKGROUND:International clinical trials are now rapidly expanding into Asia. However, the proportion of global trials is higher in South Korea compared to Japan despite implementation of similar governmental support in both countries. The difference in clinical trial environment might influence the respective physicia...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/1471-2288-13-130
更新日期:2013-10-25 00:00:00
abstract:BACKGROUND:Disease incidence and prevalence are both core indicators of population health. Incidence is generally not as readily accessible as prevalence. Cohort studies and electronic health record systems are two major way to estimate disease incidence. The former is time-consuming and expensive; the latter is not av...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-016-0288-y
更新日期:2017-01-23 00:00:00
abstract:BACKGROUND:Multiple imputation is frequently used to deal with missing data in healthcare research. Although it is known that the outcome should be included in the imputation model when imputing missing covariate values, it is not known whether it should be imputed. Similarly no clear recommendations exist on: the util...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-016-0281-5
更新日期:2017-01-09 00:00:00
abstract:BACKGROUND:Mediation is an important issue considered in the behavioral, medical, and social sciences. It addresses situations where the effect of a predictor variable X on an outcome variable Y is explained to some extent by an intervening, mediator variable M. Methods for addressing mediation have been available for ...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-017-0296-6
更新日期:2017-03-21 00:00:00
abstract:BACKGROUND:In recent months, multiple efforts have sought to characterize COVID-19 social distancing policy responses. These efforts have used various coding frameworks, but many have relied on coding methodologies that may not adequately describe the gradient in social distancing policies as states "re-open." METHODS...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-020-01174-w
更新日期:2020-12-08 00:00:00
abstract:BACKGROUND:Systematic reviews often require substantial resources, partially due to the large number of records identified during searching. Although artificial intelligence may not be ready to fully replace human reviewers, it may accelerate and reduce the screening burden. Using DistillerSR (May 2020 release), we eva...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-020-01129-1
更新日期:2020-10-15 00:00:00
abstract:BACKGROUND:Systematic reviewers seek to comprehensively search for relevant studies and summarize these to present the most valid estimate of intervention effectiveness. The more resources searched, the higher the yield, and thus time and costs required to conduct a systematic review. While there is an abundance of evi...
journal_title:BMC medical research methodology
pub_type: 杂志文章,评审
doi:10.1186/1471-2288-5-24
更新日期:2005-08-10 00:00:00
abstract:BACKGROUND:In a random effects meta-analysis model, true treatment effects for each study are routinely assumed to follow a normal distribution. However, normality is a restrictive assumption and the misspecification of the random effects distribution may result in a misleading estimate of overall mean for the treatmen...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-017-0376-7
更新日期:2017-07-19 00:00:00
abstract:BACKGROUND:The COVID-19 pandemic has evolved into one of the most impactful health crises in modern history, compelling researchers to explore innovative ways to efficiently collect public health data in a timely manner. Social media platforms have been explored as a research recruitment tool in other settings; however...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-020-01011-0
更新日期:2020-05-13 00:00:00
abstract:BACKGROUND:When conducting a meta-analysis of a continuous outcome, estimated means and standard deviations from the selected studies are required in order to obtain an overall estimate of the mean effect and its confidence interval. If these quantities are not directly reported in the publications, they must be estima...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-015-0055-5
更新日期:2015-08-12 00:00:00
abstract:BACKGROUND:The development of risk prediction models is of increasing importance in medical research - their use in practice, however, is rare. Among other reasons this might be due to the fact that thorough validation is often lacking. This study focuses on two Bayesian approaches of how to validate a prediction rule ...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/1471-2288-12-99
更新日期:2012-07-20 00:00:00
abstract:BACKGROUND:Evidence-based health care is informed by results of randomized clinical trials (RCTs) and their syntheses in meta-analyses. When the trial outcomes measured are not clearly described in trial publications, knowledge synthesis, translation, and decision-making may be impeded. While heterogeneity in outcomes ...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-020-01019-6
更新日期:2020-05-25 00:00:00
abstract:BACKGROUND:Patient-reported outcomes (PRO) are important as endpoints in clinical trials and epidemiological studies. Guidelines for the development of PRO instruments and analysis of PRO data have emphasized the need to report methods used for sample size planning. The Raschpower procedure has been proposed for sample...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-015-0011-4
更新日期:2015-03-15 00:00:00
abstract:BACKGROUND:Video stimulated recall (VSR) is a method of enhancing participants' accounts of the consultation using a video recording of the event to encourage and prompt recall in a post consultation interview. VSR is used in education and education research, and to a lesser extent in medical and nursing research. Litt...
journal_title:BMC medical research methodology
pub_type: 杂志文章,评审
doi:10.1186/1471-2288-14-101
更新日期:2014-08-30 00:00:00
abstract:BACKGROUND:Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test whether an intervention is efficacious; that is, whether it can have a beneficial effect in an ideal situation. Pragmatic trials measure effectiveness; they measure the degree of beneficial ef...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/1471-2288-3-28
更新日期:2003-12-22 00:00:00
abstract:BACKGROUND:Studies examining incident heart failure (HF) have been limited to select populations. To examine incident HF with broader generalizability, there is need to assemble a HF-free cohort using a geographically-diverse sample. We aimed to develop and validate a simple medication-based strategy for assembling a H...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-019-0890-x
更新日期:2020-03-04 00:00:00
abstract:BACKGROUND:Although in health services survey research we strive for a high response rate, this must be balanced against the need to recruit participants ethically and considerately, particularly in surveys with a sensitive nature. In survey research there are no established recommendations to guide recruitment approac...
journal_title:BMC medical research methodology
pub_type: 临床试验,杂志文章
doi:10.1186/1471-2288-13-3
更新日期:2013-01-11 00:00:00
abstract:BACKGROUND:With the increasing implementation of web-based, mobile health interventions in clinical trials, it is crucial for researchers to address the security and privacy concerns of patient information according to high ethical standards. The full process of meeting these standards is often made more complicated du...
journal_title:BMC medical research methodology
pub_type: 社论
doi:10.1186/s12874-017-0324-6
更新日期:2017-03-17 00:00:00
abstract:BACKGROUND:The reporting of randomised controlled trial (RCT) abstracts is of vital importance. The primary objective of this study was to investigate the association between structure format and RCT abstracts' quality of methodology reporting, informed by the current requirement and usage of structure formats by leadi...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-017-0469-3
更新日期:2018-01-10 00:00:00
abstract:BACKGROUND:Diagnostic problems in clinical trials are sometimes ordinal. For example, colon tumor staging was performed according to the TNM classification. However, clinical data are limited by markedly small sample sizes in some stage. METHODS:We propose a distribution-free test for detecting ordered alternatives in...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/1471-2288-13-148
更新日期:2013-12-05 00:00:00
abstract:BACKGROUND:Cancer relapses may be useful to predict the risk of death. To take into account relapse information, the Landmark approach is popular. As an alternative, we propose the joint frailty model for a recurrent event and a terminal event to derive dynamic predictions of the risk of death. METHODS:The proposed pr...
journal_title:BMC medical research methodology
pub_type: 杂志文章
doi:10.1186/s12874-015-0018-x
更新日期:2015-04-01 00:00:00